Global Substance Use Disorder Treatment Market Growth (Status and Outlook) 2023-2029

Global Substance Use Disorder Treatment Market Growth (Status and Outlook) 2023-2029

Drug addiction, also called substance use disorder, is a disease that affects a person's brain and behavior and leads to an inability to control the use of a legal or illegal drug or medication. Substances such as alcohol, marijuana and nicotine also are considered drugs.

LPI (LP Information)' newest research report, the “Substance Use Disorder Treatment Industry Forecast” looks at past sales and reviews total world Substance Use Disorder Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Substance Use Disorder Treatment sales for 2023 through 2029. With Substance Use Disorder Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Substance Use Disorder Treatment industry.

This Insight Report provides a comprehensive analysis of the global Substance Use Disorder Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Substance Use Disorder Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Substance Use Disorder Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Substance Use Disorder Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Substance Use Disorder Treatment.

The global Substance Use Disorder Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Substance Use Disorder Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Substance Use Disorder Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Substance Use Disorder Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Substance Use Disorder Treatment players cover Indivior, Pfizer, Alkermes, Novartis, Mylan, Cipla, Glenmark, Dr. Reddy's Laboratories and Teva, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Substance Use Disorder Treatment market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Alcohol Abuse Treatment
Nicotine Abuse Treatment
Drug Abuse Treatment

Segmentation by application
Hospitals
Clinics
Home Care Setting

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy's Laboratories
Teva

Please note: The report will take approximately 2 business days to prepare and deliver.